Overview
- Peptide (C)DGSRFPASQVPNRSE, corresponding to amino acid residues 1355 - 1369 of human SCN9A (Accession Q15858). Extracellular, 11th loop (3rd loop of 3rd repeat).
Human NaV1.7 (SCN9A) (extracellular) Blocking Peptide (#BLP-SC029)
- Western blot analysis of human Caco-2 colorectal adenocarcinoma cell line lysate (lanes 1 and 3) and human U-87 MG glioma cell line lysate (lanes 2 and 4):1-2. Anti-Human NaV1.7 (SCN9A) (extracellular) Antibody (#ASC-029), (1:200).
3-4. Anti-Human NaV1.7 (SCN9A) (extracellular) Antibody, preincubated with Human NaV1.7 (SCN9A) (extracellular) Blocking Peptide (BLP-SC029).
- Expression of NaV1.7 in live intact human U-87 MG glioma cell lineCell surface detection of NaV1.7 in live intact human U-87 MG cells. A. cells were stained with Anti-Human NaV1.7 (SCN9A) (extracellular) Antibody (#ASC-029), (1:50), followed by goat anti-rabbit-AlexaFluor-488 (green staining). Nuclei (blue) were visualized with Hoechst 33342. B. The same cells as in A, were stained with CellMask Orange Actin tracking dye (orange), to help visualize cell membranes.
- Cell surface detection of NaV1.7 by indirect flow cytometry in live intact human U-87 MG glioma cell line:___ Cells.
___ Cells + goat-anti-rabbit-PE.
___ Cells + Anti-Human NaV1.7 (SCN9A) (extracellular) Antibody (#ASC-029), (2.5μg) + goat-anti-rabbit-PE.
- Wu, L. et al. (2002) NeuroReport 13, 2547.
- Fang, X. et al. (2002) J. Neurosci. 22, 7425.
- Fjell, J. et al. (2000) NeuroReport 11, 199.
- Baker, M.D. and Wood, J.N. (2001) Trends Pharmacol. Sci. 22, 27.
- Lai, J. et al. (2003) Curr. Opin. Neurobiol. 13, 291.
- Isom, L.L. (2001) Neuroscientist 7, 42.
- Catterall, W.A. et al. (2003) Pharmacol. Rev. 55, 575.
- Catterall, W.A. et al. (2005) Pharmacol. Rev. 57, 397.
- Yang, Y. et al. (2004) J. Med. Genet. 41, 171.
- Cummins, T.R. et al. (2004) J. Neurosci. 24, 8232.
- Dray, A. (2008) Br. J. Anaesth. 101, 48.
Voltage-gated sodium channels (NaV) are essential for the generation of action potentials and for cell excitability1. NaV channels are activated in response to depolarization and selectively allow the flow of Na+ ions. To date, nine NaV α subunits have been cloned and named NaV1.1-NaV1.94-5. The NaV channels are classified into two groups according to their sensitivity to tetrodotoxin (TTX): TTX-sensitive (NaV1.1, NaV1.2, NaV1.3, NaV1.4, NaV1.6 and NaV1.7) and TTX-resistant (NaV1.5, NaV1.8 and NaV1.9)2-3.
Mammalian sodium channels are heterotrimers composed of a central, pore-forming α subunit and two auxiliary β subunits. The expression of the α subunit isoform is developmentally regulated and tissue specific. Na+ channels in the adult central nervous system and heart contain β1 through β4 subunits, whereas Na+ channels in adult skeletal muscle have only the β1 subunit6,8.
NaV1.7 is predominantly expressed in dorsal root ganglions (DRG) of the peripheral nervous system. Dominant gain of function mutations in the NaV1.7 gene are associated with erythermalgia (a rare autosomal disease characterized by sporadic burning pain accompanied by redness and heat in the extremities).9-11 Loss of function mutations in NaV1.7 channels leads to complete ablation of pain perception in humans.11 These recent findings highlight the role of this NaV isoform and the subset of DRG neurons that express this channel in physiological pain sensation.
Application key:
Species reactivity key:
Anti-Human NaV1.7 (SCN9A) (extracellular) Antibody (#ASC-029) is a highly specific antibody directed against an extracellular epitope of the human protein. The antibody can be used in western blot, immunocytochemistry and flow cytometry applications. It has been designed to recognize the human NaV1.7 protein. Not recommended for rat or mouse samples.